Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SkinVision

Explore full profile

Skin cancer detection mobile app

Amsterdam, NetherlandsFounded 2011Health Tech & Medtech
Valuation $25–50M Last recorded · 2018
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SkinVision and the history behind them.

About SkinVision

SkinVision operates in the digital health sector, providing an AI-powered mobile application designed for early detection of skin cancer, including melanoma. The app serves a broad range of clients, from individual users concerned about skin health to healthcare providers seeking reliable diagnostic tools. SkinVision leverages advanced machine learning algorithms to analyze skin lesions and provide users with immediate risk assessments, which can then be shared with dermatologists for further evaluation.

Read full description

The company operates on a subscription-based business model, generating revenue through monthly or annual fees paid by users for access to its premium features. These features include unlimited skin checks, personalized skin health advice, and a comprehensive health path tailored to each user's needs.

SkinVision's market includes both direct-to-consumer (DTC) and business-to-business (B2B) segments. In the DTC segment, the app is marketed to individuals who are proactive about their skin health. In the B2B segment, SkinVision collaborates with healthcare providers, insurance companies, and corporate wellness programs to integrate its technology into broader health management systems.

The company differentiates itself through its clinically validated technology, partnerships with leading dermatologists, and a strong focus on user experience. By providing timely and accurate skin health assessments, SkinVision aims to reduce the incidence of late-stage skin cancer diagnoses and improve overall skin health outcomes.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Amsterdam, Netherlands
Sector
Health Tech & Medtech

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • LEO pharma
  • LEO Innovation Lab
  • PHS Capital
Team profiled 23 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇳🇱 Netherlands64.8%
🇦🇷 Argentina9.3%
🇦🇺 Australia3.7%
🇷🇴 Romania3.7%
🇪🇸 Spain1.9%
Top 5 of 13 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SkinVision on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SkinVision on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.